Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA
ABNT
BOACNIN, Marina do Rosário et al. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 09 set. 2024. , 2012APA
Boacnin, M. do R., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2012). Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 set. 09 ]Vancouver
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 set. 09 ]